Masood Faghih Dinevari1, Mohammad Hossein Somi1, Elham Sadeghi Majd2, Mahdieh Abbasalizad Farhangi3, Zeinab Nikniaz4. 1. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Community Nutrition Department, Tabriz University of Medical Sciences, Tabriz, Iran. 4. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. znikniaz@hotmail.com.
Abstract
BACKGROUND: There are limited number of studies with controversial findings regarding the association between anemia at admission and coronavirus disease 2019 (COVID-19) outcomes. Therefore, in this research, we aimed to investigate the prospective association between anemia and COVID-19 outcomes in hospitalized patients in Iran. METHODS: In this prospective study, the data of 1274 consecutive patients hospitalized due to COVID-19 were statistically analyzed. All biomarkers, including hemoglobin and high-sensitivity C-reactive protein (hs-CRP) levels were measured using standard methods. Anemia was defined as a hemoglobin (Hb) concentration of less than 13 g/dL and 12 g/dL in males and females, respectively. Assessing the association between anemia and COVID-19 survival in hospitalized patients was our primary endpoint. RESULTS: The mean age of the participants was 64.43 ± 17.16 years, out of whom 615 (48.27%) were anemic subjects. Patients with anemia were significantly older (P = 0.02) and had a higher frequency of cardiovascular diseases, hypertension, kidney disease, diabetes, and cancer (P < 0.05). The frequency of death (anemic: 23.9% vs. nonanemic: 13.8%), ICU admission (anemic: 27.8% vs. nonanemic:14.71%), and ventilator requirement (anemic: 35.93% vs. nonanemic: 20.63%) were significantly higher in anemic patients than in nonanemic patients (P < 0.001). According to the results of regression analysis, after adjusting for significant covariate in the univariable model, anemia was independently associated with mortality (OR: 1.68, 95% CI: 1.10, 2.57, P = 0.01), ventilator requirement (OR: 1.74, 95% CI: 1.19, 2.54, P = 0.004), and the risk of ICU admission (OR: 2.06, 95% CI: 1.46, 2.90, P < 0.001). CONCLUSION: The prevalence of anemia in hospitalized patients with COVID-19 was high and was associated with poor outcomes of COVID-19.
BACKGROUND: There are limited number of studies with controversial findings regarding the association between anemia at admission and coronavirus disease 2019 (COVID-19) outcomes. Therefore, in this research, we aimed to investigate the prospective association between anemia and COVID-19 outcomes in hospitalized patients in Iran. METHODS: In this prospective study, the data of 1274 consecutive patients hospitalized due to COVID-19 were statistically analyzed. All biomarkers, including hemoglobin and high-sensitivity C-reactive protein (hs-CRP) levels were measured using standard methods. Anemia was defined as a hemoglobin (Hb) concentration of less than 13 g/dL and 12 g/dL in males and females, respectively. Assessing the association between anemia and COVID-19 survival in hospitalized patients was our primary endpoint. RESULTS: The mean age of the participants was 64.43 ± 17.16 years, out of whom 615 (48.27%) were anemic subjects. Patients with anemia were significantly older (P = 0.02) and had a higher frequency of cardiovascular diseases, hypertension, kidney disease, diabetes, and cancer (P < 0.05). The frequency of death (anemic: 23.9% vs. nonanemic: 13.8%), ICU admission (anemic: 27.8% vs. nonanemic:14.71%), and ventilator requirement (anemic: 35.93% vs. nonanemic: 20.63%) were significantly higher in anemicpatients than in nonanemic patients (P < 0.001). According to the results of regression analysis, after adjusting for significant covariate in the univariable model, anemia was independently associated with mortality (OR: 1.68, 95% CI: 1.10, 2.57, P = 0.01), ventilator requirement (OR: 1.74, 95% CI: 1.19, 2.54, P = 0.004), and the risk of ICU admission (OR: 2.06, 95% CI: 1.46, 2.90, P < 0.001). CONCLUSION: The prevalence of anemia in hospitalized patients with COVID-19 was high and was associated with poor outcomes of COVID-19.
Authors: Huong Q Nguyen; Lynna Chu; In-Liu Amy Liu; Janet S Lee; David Suh; Brian Korotzer; George Yuen; Smita Desai; Karen J Coleman; Anny H Xiang; Michael K Gould Journal: Ann Am Thorac Soc Date: 2014-06
Authors: Shrishtidhar Prasad; Suprava Patel; Ajoy K Behera; Dibakar Sahu; Seema Shah; Rachita Nanda; Eli Mohapatra Journal: J Family Med Prim Care Date: 2022-05-14
Authors: Badriyah Alotaibi; Thanaa A El-Masry; Mohamed G Seadawy; Mahmoud H Farghali; Bassem E El-Harty; Asmaa Saleh; Yasmen F Mahran; Jackline S Fahim; Mohamed S Desoky; Mohamed M E Abd El-Monsef; Maisra M El-Bouseary Journal: Heliyon Date: 2022-01-31
Authors: Sol Carriazo; Sebastian Mas-Fontao; Clara Seghers; Jaime Cano; Elena Goma; Alejandro Avello; Alberto Ortiz; Emilio Gonzalez-Parra Journal: Clin Kidney J Date: 2021-12-20
Authors: Joe N Frost; Fergus Hamilton; Hal Drakesmith; Peter Ghazal; David Arnold; Karen T Elvers; Akshay Shah; Andrew E Armitage; Alice Milne; Jorgen McKernon; Marie Attwood; Yi-Ling Chen; Luzheng Xue; Jonathan Youngs; Nicholas M Provine; Tihana Bicanic; Paul Klenerman Journal: Wellcome Open Res Date: 2022-06-21